Symposium: What does the microbiome tell us about prevention and treatment of AD/ADRD?

Simple item page
dc.check.date2025-04-09en
dc.check.infoAccess to this article is restricted until 6 months after publication by request of the publisheren
dc.contributor.authorCapocchi, Joia K.en
dc.contributor.authorFigueroa-Romero, Claudiaen
dc.contributor.authorDunham, Sage J. B.en
dc.contributor.authorFaraci, Ginaen
dc.contributor.authorRothman, Jason A.en
dc.contributor.authorWhiteson, Katrine L.en
dc.contributor.authorSeo, Dong-ohen
dc.contributor.authorHoltzman, David M.en
dc.contributor.authorGrabrucker, Stefanieen
dc.contributor.authorNolan, Yvonne M.en
dc.contributor.authorKaddurah-Daouk, Rimaen
dc.contributor.authorJett, David A.en
dc.contributor.funderGood Ventures Foundationen
dc.contributor.funderCure Alzheimer’s Funden
dc.contributor.funderScience Foundation Irelanden
dc.contributor.funderNational Institute on Agingen
dc.contributor.funderFoundation for the National Institutes of Healthen
dc.date.accessioned2024-11-26T13:01:13Z
dc.date.available2024-11-26T13:01:13Z
dc.date.issued2024-10-09en
dc.description.abstractAlzheimer's disease (AD) and Alzheimer's disease-related dementias (ADRDs) are broad-impact multifactorial neurodegenerative diseases. Their complexity presents unique challenges for developing effective therapies. This review highlights research presented at the 2024 Society for Neuroscience meeting which emphasized the gut microbiome's role in AD pathogenesis by influencing brain function and neurodegeneration through the microbiota–gut–brain axis. This emerging evidence underscores the potential for targeting the gut microbiota to treat AD/ADRD.en
dc.description.sponsorshipNational Institute on Aging (U54AG054349; T32 AG00096-38; R01AG046171; RF1AG051550; RF1AG057452; R01AG059093; RF1AG058942; U01AG061359; U19AG063744); Foundation for the National Institutes of Health (DAOU16AMPA)en
dc.description.statusPeer revieweden
dc.description.versionPublished Versionen
dc.format.mimetypeapplication/pdfen
dc.identifier.articleide1295242024en
dc.identifier.citationCapocchi, J. K., Figueroa-Romero, C., Dunham, S. J., Faraci, G., Rothman, J. A., Whiteson, K. L., Seo, D. O., Holtzman, D. M., Grabrucker, S., Nolan, Y. M. and Kaddurah-Daouk, R. (2024) 'SSymposium: What does the microbiome tell us about prevention and treatment of AD/ADRD?', Journal of Neuroscience, 44(41), e1295242024 (6pp). https://doi.org/10.1523/jneurosci.1295-24.2024en
dc.identifier.doihttps://doi.org/10.1523/jneurosci.1295-24.2024en
dc.identifier.eissn1529-2401en
dc.identifier.endpage6en
dc.identifier.issn0270-6474en
dc.identifier.issued41en
dc.identifier.journaltitleJournal of Neuroscienceen
dc.identifier.startpage1en
dc.identifier.urihttps://hdl.handle.net/10468/16676
dc.identifier.volume44en
dc.language.isoenen
dc.publisherSociety for Neuroscienceen
dc.relation.ispartofThe Journal of Neuroscienceen
dc.rights© 2024, the Authors. Published by the Society for Neuroscience.en
dc.subjectAlzheimer's disease (AD)en
dc.subjectAlzheimer's disease-related dementia (ADRD)en
dc.subjectGut microbiomeen
dc.subjectBrain functionen
dc.subjectNeurodegenerationen
dc.subjectMicrobiota–gut–brain axisen
dc.titleSymposium: What does the microbiome tell us about prevention and treatment of AD/ADRD?en
dc.typeArticle (peer-reviewed)en
oaire.citation.issue41en
oaire.citation.volume44en
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
e1295242024.full.pdf
Size:
176.98 KB
Format:
Adobe Portable Document Format
Description:
Published Version
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
2.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
APC Microbiome Ireland - Journal Articles
Anatomy and Neuroscience - Journal Articles